| 000 | 01781 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515070225.0 | ||
| 264 | 0 | _c20070801 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0862-8408 | ||
| 024 | 7 |
_a10.33549/physiolres.931113 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPotáčová, A | |
| 245 | 0 | 0 |
_aEvaluation of ECG time intervals in a rabbit model of anthracycline-induced cardiomyopathy: a useful tool for assessment of cardioprotective agents. _h[electronic resource] |
| 260 |
_bPhysiological research _c2007 |
||
| 300 |
_a251-254 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAldehydes _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiomyopathies _xblood |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDaunorubicin |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDrug Evaluation, Preclinical _xmethods |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aHeart Conduction System _xdrug effects |
| 650 | 0 | 4 |
_aHydrazones _xpharmacology |
| 650 | 0 | 4 |
_aIron Chelating Agents _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aPyridoxal _xanalogs & derivatives |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 |
_aRazoxane _xpharmacology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTroponin T _xblood |
| 700 | 1 | _aAdamcová, M | |
| 700 | 1 | _aČajnáková, H | |
| 700 | 1 | _aHrbatová, L | |
| 700 | 1 | _aSterba, M | |
| 700 | 1 | _aPopelová, O | |
| 700 | 1 | _aŠimůnek, T | |
| 700 | 1 | _aPonka, P | |
| 700 | 1 | _aGersl, V | |
| 773 | 0 |
_tPhysiological research _gvol. 56 _gno. 2 _gp. 251-254 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.33549/physiolres.931113 _zAvailable from publisher's website |
| 999 |
_c17048645 _d17048645 |
||